Evotec SE EVO Stock
Evotec SE Price Chart
Evotec SE EVO Financial and Trading Overview
| Evotec SE stock price | 5.16 USD |
| Previous Close | 11.81 USD |
| Open | 11.78 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 11.77 - 11.88 USD |
| 52 Week Range | 7.8 - 15.04 USD |
| Volume | 4.58K USD |
| Avg. Volume | 35.4K USD |
| Market Cap | 4.23B USD |
| Beta (5Y Monthly) | 0.99272 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.2 USD |
EVO Valuation Measures
| Enterprise Value | 4.09B USD |
| Trailing P/E | N/A |
| Forward P/E | 40.862415 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.630141 |
| Price/Book (mrq) | 3.5273404 |
| Enterprise Value/Revenue | 5.446 |
| Enterprise Value/EBITDA | 50.052 |
Trading Information
Evotec SE Stock Price History
| Beta (5Y Monthly) | 0.99272 |
| 52-Week Change | -2.86% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.04 USD |
| 52 Week Low | 7.8 USD |
| 50-Day Moving Average | 10.55 USD |
| 200-Day Moving Average | 9.62 USD |
EVO Share Statistics
| Avg. Volume (3 month) | 35.4K USD |
| Avg. Daily Volume (10-Days) | 15.2K USD |
| Shares Outstanding | 353.9M |
| Float | 286.27M |
| Short Ratio | 0.81 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.73% |
| Shares Short | 17.11K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -23.37% |
| Operating Margin (ttm) | 2.70% |
| Gross Margin | 23.16% |
| EBITDA Margin | 10.88% |
Management Effectiveness
| Return on Assets (ttm) | 0.56% |
| Return on Equity (ttm) | -13.69% |
Income Statement
| Revenue (ttm) | 751.45M USD |
| Revenue Per Share (ttm) | 2.13 USD |
| Quarterly Revenue Growth (yoy) | 28.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | 81.77M USD |
| Net Income Avi to Common (ttm) | -175655008 USD |
| Diluted EPS (ttm) | -0.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 718.49M USD |
| Total Cash Per Share (mrq) | 2.03 USD |
| Total Debt (mrq) | 506.67M USD |
| Total Debt/Equity (mrq) | 42.68 USD |
| Current Ratio (mrq) | 3.179 |
| Book Value Per Share (mrq) | 3.3595 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 203.11M USD |
| Levered Free Cash Flow (ttm) | -150347744 USD |
Profile of Evotec SE
| Country | United States |
| State | N/A |
| City | Hamburg |
| Address | Essener Bogen 7 |
| ZIP | 22419 |
| Phone | 49 40 560 81 0 |
| Website | https://www.evotec.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4952 |
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Q&A For Evotec SE Stock
What is a current EVO stock price?
Evotec SE EVO stock price today per share is 5.16 USD.
How to purchase Evotec SE stock?
You can buy EVO shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evotec SE?
The stock symbol or ticker of Evotec SE is EVO.
Which industry does the Evotec SE company belong to?
The Evotec SE industry is Drug Manufacturers-Specialty & Generic.
How many shares does Evotec SE have in circulation?
The max supply of Evotec SE shares is 503.69M.
What is Evotec SE Price to Earnings Ratio (PE Ratio)?
Evotec SE PE Ratio is now.
What was Evotec SE earnings per share over the trailing 12 months (TTM)?
Evotec SE EPS is -0.28 USD over the trailing 12 months.
Which sector does the Evotec SE company belong to?
The Evotec SE sector is Healthcare.
Evotec SE EVO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}